Johnson & Johnson and Takeda have partnered with the Israeli government and OrbiMed Israel Partners to build FutuRx, a collectively owned biotech incubator. The incubator is part of a global portfolio of partnerships and investments by Johnson & Johnson Innovation, the pharma's early stage collaborations unit.